Inhibitory effect of PTI--1(PC--3) on PC--3 cell line by using short--hairpin siRNA expression vector pEGFP/U6 {\sl in vitro}

Song Bin,Wang He,Zhao Jing,Qin Weijun,Yang Angang
2005-01-01
Abstract:AIM: To construct the short-hairpin RNA (shRNA) eukaryotic expression vector specific to prostate carcinoma tumor-inducing gene 1 (PC-3) [PTI-1 (PC-3)], which is overexpressed in human prostate carcinoma PC-3 cell line, and to observe the silencing effect of the established vector on PTI-1 (PC-3). METHODS: The shRNA specific to PTI-1 (PC-3) was synthesized and inserted into pEGFP/U6 by gene recombination technology to construct the expression vector, pEGFP/U6-mPs, which was then transfected into the cultured PC-3 cells. The cell total RNA was extracted to perform RT-PCR and the whole cell protein was extracted and detected by Western blot with rabbit-anti-human PTI-1 (PC-3) polyclonal antibody. RESULTS: pEGFP/U6-mPs expression vector was successfully constructed. Lipofectamine2000 mediated gene transfection of pEGFP/U6-mPs led to cell-death at 48h after transfection. The down-regulations of both the PTI-1 (PC-3) mRNA level and the PTI-1 (PC-3) protein level were also observed. CONCLUSION: The pEGFP/U6-mPs expression vector can inhibit the expression of PTI-1 (PC-3) gene in human prostate carcinoma PC-3 cell line, which may down-regulate the level of PTI-1 protein expression. Translational infidelity, the role of PTI-1 (PC-3) protein, is probably degraded, which may be responsible for the death of the cancer cells. The PTI-1 (PC-3) gene is further confirmed as a dominant-acting oncogene. The specificity of the RNA interference may lead to a novel approach of clinical gene therapy in treating prostate carcinoma.
What problem does this paper attempt to address?